|
⚲
|
| Keyboard |
| Turtle Cameron
✚
|
|
|---|---|
| CIK # | 0001758363 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001758363] | |
| 4 | [0001758363] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Turtle Cameron | |
| Spyre Therapeutics Inc | |
| Damora Therapeutics Inc | |
| Oruka Therapeutics Inc | |
| Eidos Therapeutics Inc | |
| BridgeBio Pharma LLC |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Damora Therapeutics Inc DMRA
Stock Option (right to buy) · derivative
|
2026-03-23 | Grant | 37,313 | $0.00 | |
|
Spyre Therapeutics Inc SYRE
Common Stock
|
2026-03-02 | Sell | 9,100 | $42.49 | 386,659 |
|
Spyre Therapeutics Inc SYRE
Common Stock
|
2026-03-02 | Sell | 5,900 | $41.73 | 246,207 |
|
Spyre Therapeutics Inc SYRE
Common Stock
|
2026-02-02 | Sell | 957 | $31.82 | 30,452 |
|
Spyre Therapeutics Inc SYRE
Common Stock
|
2026-02-02 | Sell | 14,043 | $32.87 | 461,593 |
|
Spyre Therapeutics Inc SYRE
Stock Option (Right to Buy) · derivative
|
2026-01-09 | Grant | 528,000 | $0.00 | |
|
Spyre Therapeutics Inc SYRE
Common Stock
|
2026-01-02 | Sell | 2,191 | $31.79 | 69,652 |
|
Spyre Therapeutics Inc SYRE
Common Stock
|
2026-01-02 | Sell | 100 | $32.39 | 3,239 |
|
Spyre Therapeutics Inc SYRE
Common Stock
|
2026-01-02 | Sell | 12,709 | $30.47 | 387,243 |
|
Spyre Therapeutics Inc SYRE
Common Stock
|
2025-12-01 | Sell | 4,005 | $29.83 | 119,469 |
|
Spyre Therapeutics Inc SYRE
Common Stock
|
2025-12-01 | Sell | 10,995 | $28.73 | 315,886 |
|
Spyre Therapeutics Inc SYRE
Common Stock
|
2025-11-03 | Sell | 28,155 | $23.13 | 651,225 |
|
Spyre Therapeutics Inc SYRE
Common Stock
|
2025-11-03 | Sell | 16,845 | $23.66 | 398,553 |
|
Oruka Therapeutics Inc ORKA
Stock Option (right to buy) · derivative
|
2025-06-02 | Grant | 17,500 | $0.00 | |
|
Spyre Therapeutics Inc SYRE
Stock Option (Right to Buy) · derivative
|
2025-01-15 | Grant | 370,000 | $0.00 | |
|
Spyre Therapeutics Inc SYRE
Common Stock
|
2024-02-15 | Grant | 400 | $9.82 | 3,928 |
|
Spyre Therapeutics Inc SYRE
Stock Option (Right to Buy) · derivative
|
2024-02-01 | Grant | 277,750 | $0.00 | |
|
Spyre Therapeutics Inc AGLE
Common Stock
|
2023-11-24 | Conversion | 723,440 | $0.00 | |
|
Spyre Therapeutics Inc AGLE
Series A Preferred Stock · derivative
|
2023-11-24 | Conversion | 18,086 | $0.00 | |
|
Spyre Therapeutics Inc AGLE
Stock Option (Right to Buy) · derivative
|
2023-11-22 | Grant | 374,000 | $0.00 | |
| showing 20 of 140 most recent transactions | |||||